Flu, cancer, HIV: after Covid success, what next for mRNA vaccines?

The technology was viewed with scepticism before the pandemic but there is now growing confidence about its use It is one of the most remarkable success stories of the pandemic: the unproven technology that delivered the Moderna and Pfizer/BioNTech vac…

WHO endorses use of world’s first malaria vaccine in Africa

World Health Organization’s director general hails ‘historic day’ in fight against parasitic diseaseThe World Health Organization has recommended the widespread rollout of the first malaria vaccine, in a move experts hope could save tens of thousands o…

Malaria trial shows ‘striking’ 70% reduction in severe illness in children

A study in Burkina Faso and Mali suggests combining anti-malarial drugs and vaccination could reduce deaths and hospitalisationsA trial combining vaccinations and prevention drugs has substantially lowered the number of children dying of malaria in two…

Genetic engineering test with mosquitoes ‘may be game changer’ in eliminating malaria

UK scientist says gene-drive study rendering female insects infertile may lead to ‘self destruct mosquito’ field tests within 10 yearsScientists have successfully wiped out a population of malaria-transmitting mosquitoes by using a radical form of gene…

BioNTech founder Uğur Şahin and Mayfield’s Ursheet Parikh are coming to Disrupt

It’s hard to argue that any technology company has had a greater impact in the past decade than BioNTech, the mRNA-based therapeutics pioneer behind the world’s most widely-used COVID-19 vaccine. Developed in record time in partnership with Pfizer, thanks to an existing partnership to work on immunization for the common flu, BioNTech’s mRNA inoculation is […]